RAPPORT
LIVE

Serial Number

97630353

Owner

Rapport Therapeutics, Inc.

Attorney

Shane Rumbaugh

Filing Date

Oct 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

RAPPORT Trademark

Serial Number: 97630353

RAPPORT is a trademark filed by Rapport Therapeutics, Inc. on October 13, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Rapport Therapeutics, Inc.

1325 Boylston Street
Boston, MA 02215

Entity Type: 03

Trademark Details

Filing Date

October 13, 2022

Registration Date

Not Registered

Published for Opposition

December 19, 2023

Goods & Services

Biological preparations for scientific purposes for use in targeting AMPA receptors

Pharmaceutical preparations for treating neurological disorders, pain, acoustic trauma, epilepsy, seizures, and mood disorders; chemical and biochemical preparations and substances for medical purposes for treatment of neurological disorders, pain, acoustic trauma, epilepsy, seizures, and mood disorders; biological preparations for the treatment of neurological disorders, pain, acoustic trauma, epilepsy, seizures, and mood disorders; chemical and biochemical preparations for medical purposes for use in targeting AMPA receptors; pharmaceutical preparations for use in targeting AMPA receptors; biological preparations for medical purposes for use in targeting AMPA receptors

Custom manufacture of biochemical systems in the nature of pharmaceuticals, namely, custom manufacture of systems for targeting AMPA receptors; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for the treatment of neurological disorders, pain, acoustic trauma, epilepsy, seizures, and mood disorders

Providing information in the fields of treatment of neurologic disorders and treatments involving pharmaceuticals

Pharmaceutical research and development in the field of neurologic disorders; pharmaceutical drug development services; scientific research; pharmaceutical research services; research and development in the pharmaceutical and biotechnology fields; providing information in the fields of research on neurologic disorders, drug development, research on pharmaceuticals and biotechnology

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2026 EXRA
SOU EXTENSION 4 GRANTED
Jan 28, 2026 EX4G
SOU EXTENSION 4 FILED
Jan 28, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 28, 2026 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 5, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 5, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 5, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 16, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jul 15, 2025 EX3G
SOU EXTENSION 3 FILED
Jul 15, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 15, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 4, 2025 EXRA
SOU EXTENSION 2 GRANTED
Feb 4, 2025 EX2G
SOU EXTENSION 2 FILED
Feb 4, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 31, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jul 31, 2024 EX1G
SOU EXTENSION 1 FILED
Jul 31, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 31, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 16, 2024 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 13, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 19, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 29, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 4, 2023 GNRN
NON-FINAL ACTION E-MAILED
Aug 4, 2023 GNRT
NON-FINAL ACTION WRITTEN
Aug 4, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 28, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 27, 2022 NWOS
NEW APPLICATION ENTERED
Oct 17, 2022 NWAP